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Case Report
Minimally Symptomatic Severe Hypercalcaemia in a Patient with Parathyroid
Carcinoma
Aisha Sheikh, Najmul Islam
Department of Medicine, Aga Khan University Hospital, Karachi.
Abstract
The case of a 38 years old man with generalized
pains fatigue, anorexia, constipation, polyuria serum calci-
um level of 20.6mg/dl in paired renal function parathyroid
hormone is presented. Sestamibi scan showed a functioning
left inferior parathyroid tumor, which was successfully
removed. Before surgery he was managed with rehydration,
diuretics and pamidronate infusion.
Five months post surgery the serum calcium levels
are normal and renal function has improved.
Introduction
Serum Calcium level above 14mg/dl is considered as
severe hypercalcaemia and the patients are usually acutely
ill necessitating urgent hospitalization and treatment.1
Clinical manifestations affect the neuromuscular, gastroin-
testinal, renal, skeletal, and cardiovascular systems. The
most common causes of hypercalcaemia are primary hyper-
parathyroidism and malignancy.1 Hypercalcaemic crisis is a
life-threatening emergency. Aggressive intravenous rehy-
dration is the mainstay of management in severe hypercal-
caemia, and antiresorptive agents, such as calcitonin and
bisphosphonates, frequently can alleviate the clinical mani-
festations of hypercalcaemic disorders.1,2 We report a case
that had serum calcium of more than 20mg/dl and he walked
into the endocrine clinic.
Case Report
A 38 years old man who had one year history of gen-
eralized pains more marked in shoulders and legs, fatigabil-
ity, anorexia, constipation and polyuria was seen at a med-
ical care facility and was found to have a serum calcium of
17.6mg/dl (normal range: 8.6-10.5mg/dl) with an intact
Parathyroid Hormone (PTH) of 1205pg/ml (normal range:
7-53mg/dl). Suspecting Parathyroid adenoma a Sestamibi
scan was done which showed a functioning left inferior
parathyroid tumor. He had a pepper pot skull on radiograph.
He was treated with bisphosphonates with which his symp-
toms improved and there was a reported fall in serum calci-
um to 10.4mg/dl. He was advised surgery but he was lost to
follow up.
Six months later he presented to our endocrine clin-
ic with history of pain in extremities, weakness, fatigability,
anorexia, constipation and vomiting of one week duration
and had a report of his serum calcium which was 20.6mg/dl.
He was alert and oriented and his clinical examination was
unremarkable except that there was a small nodule (<1cm)
palpable on the left side of the neck. He was admitted and
was treated with normal saline infusions followed by
pamidronate infusion and intravenous frusemide. He had a
serum creatinine of 3.3mg/dl which was thought to be due
to renal impairment secondary to hypercalcemia. His intact
PTH was 2240pg/ml. He was screened for multiple
endocrine neoplasia which turned out to be negative. His
25-hydroxyvitamin D level was 9.4mg/dl (normal range:
9.0-37.6mg/dl). With treatment his serum calcium fell to
11.3 g/dl and then he underwent surgical removal in which
left inferior parathyroidectomy and left thyroid lobectomy
was done. Immediately after surgery his PTH level came
down to 138pg/ml.
The histopathology revealed cellular neoplastic
lesion composed of pleomorphic cells arranged in trabecu-
lae and clusters incompletely separated by thick fibrous
bands. The cells were pleomorphic having clear cytoplasm
with indistinct cell boundaries. Nuclei showed pleomor-
phism and hyperchromasia with inconspicuous nucleoli.
Increased mitotic activity was noted. Cellular invasion was
identified. Neoplastic cells were seen abutting the thyroid
acini (Figure). These findings were consistent with parathy-
roid carcinoma. 
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Figure. Parathyroid Carcinoma infiltrating the thyroid gland
Our patient's serum calcium levels remained in nor-
mal range in the immediate postoperative period on supple-
mental calcium and calcitriol. Five months after surgery his
serum calcium levels are within normal range on follow
ups. His serum creatinine level has also come down to
2.0mg/dl but has not normalized.
Discussion
The most common cause of hypercalcaemia is pri-
mary hyperparathyroidism, followed by malignancy.
Together they account for more than 90% of cases2; howev-
er, malignancy accounts for the majority of cases of severe
hypercalcaemia and hypercalcaemic crises.1 A case of
hypercalcaemic crisis (serum calcium 5.9mmol or
23.6mg/dl) due to parathyroid hormone related protein
(PTHrP) secreting pancreatic neuroendocrine tumor in
pregnancy has been reported by Abraham et al.3
Hypercalcaemia in the setting of raised intact
parathyroid hormone is pathognomonic for primary hyper-
parathyroidism. Benign primary hyperparathyroidism rarely
produces severe hypercalcaemia and/or hypercalcaemic
crises, unless renal insufficiency and/or dehydration is
superimposed on the underlying hyperparathyroidism1. In
contrast parathyroid carcinoma is associated with severe
hypercalcaemia i.e. more than 14mg/dl level.1,4 Severe
hypercalcaemia produces gastro-intestinal symptoms-
anorexia, nausea, vomiting and constipation, neuro-psychi-
atric symptoms-fatigue, lethargy, poor concentration,
depression, obtundation, coma and occasionally causes car-
diovascular complications-bradyarrhythmias, heart block
and cardiac arrest.1,5 Our patient was minimally sympto-
matic with serum calcium of 20.6mg/dl which might be due
to the chronic nature of his illness.
Parathyroid carcinoma is an uncommon cause of
PTH-dependent hypercalcaemia4,6 and it accounts for less
than 1% of patients with primary hyperparathyroidism.7
Different case series have reported serum calcium in the
range of 9.9-18.4mg/dl8,9 and 11.4-15.6mg/dl9 in patients
with parathyroid carcinomas. Spinelli C et al reported three
cases of parathyroid carcinoma, one of them had serum cal-
cium of 20.2mg/dl.10 Our patient had serum calcium of
20.6mg/dl which is the highest reported with parathyroid
carcinomas.
The initial treatment of severe hypercalcaemia is the
same regardless of the etiology. Therapy is aimed at increas-
ing renal excretion of calcium and decreasing bone resorp-
tion. Patients with hypercalcaemic crisis are volume deplet-
ed and initial therapy should be intravenous hydration with
isotonic saline as was done in our patient. Following aggres-
sive rehydration intravenous loop diuretics are used to
inhibit calcium resorption in the distal tubule.
Bisphosphonates, which directly inhibit osteoclast activity,
are the most effective of the pharmacological agents.
Pamidronate has often been used in such cases as was used
in our patient. Calcitonin, glucocorticoids and rarely pli-
amycin and gallium nitrate have been used for hypercal-
caemic crisis with variable success. In patients with renal
failure, dialysis with a low or zero calcium dialysate should
be initiated.1,5
The single most effective therapy for parathyroid
carcinoma is complete resection of the primary lesion at the
time of initial operation when extensive local invasion and
distant metastases are less likely.5 Surgical treatment results
in prompt correction of serum calcium and parathyroid hor-
mone with gradual resolution of the metabolic conse-
quences of severe hypercalcaemia. The prognosis of
parathyroid carcinoma is quite variable. Five-year survival
rates vary from 40-86%.5 Persistent hypercalcaemia follow-
ing initial surgery is a poor prognostic indicator as 60% of
patients die within 3 years.11
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